Arrowhead Pharmaceuticals, Inc.ARWRNASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank86
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Latest
125.96%
↑ 422% vs avg
Percentile
P86
Within normal range
Streak
1 yr
Consecutive growthAccelerating
Average
24.13%
Historical baseline
PeriodValue
2025125.96%
2024-82.78%
2023-75.02%
2022-227.86%
2021237.11%
2020-166.91%
2019431.04%
2018-52.70%
201753.35%
2016-0.90%